A survey has ranked high earners from technology-licensing income among US universities, hospitals, research institutions and investment firms during fiscal year 2007.
Of the 185 respondents that allowed their data to be published, New York University earned the most at $791 million, much of it from selling partial royalty rights to the autoimmune-disease drug Remicade. Massachusetts General Hospital in Boston was second with $346 million. Columbia University in New York, which has licensed drug therapies, medical devices and consumer electronics technologies, took in $136 million.
Research at the institutions surveyed resulted in the creation of 555 start-up companies, led by the University of California System with 38. The survey, released on 26 January, was conducted by the non-profit Association of University Technology Managers.